Table 3.

Survival and prognosis for hepatoid carcinoma of the pancreas

	Case n	Median (range)	Mean ± SD	1-year survival	5-year survival	P value
Total	22	13.0 (2.0–101.0)	18.1 ± 21.8	71.1 %	40.4 %
Location						0.780
Pancreatic head	9	8.0 (3.0–48.0)	14.3 ± 14.8	77.8 %	29.2 %
Pancreatic body-tail	13	14.0 (2.0–101.0)	20.7 ± 25.9	51.3 %	51.3 %
Histopathology						0.763
Pure hepatoid carcinoma	13	12.0 (2.0–48.0)	15.5 ± 13.3	56.1 %	56.1 %
Mixed hepatoid carcinoma	8	11.0 (2.8–101.0)	22.7 ± 32.9	75.0 %	25.0 %
Metastasis						0.001
No	13	15.0 (4.0–48.0)	18.5 ± 12.3	88.9 %	59.3 %
Yes	8	4.5 (2.0–101.0)	18.9 ± 33.8	25.0 %	12.5 %
Lymph node metastasis						<0.001
No	15	15.0 (4.0–101.0)	23.7 ± 24.5	83.3 %	62.5 %
Yes	4	4.5 (2.0–12.0)	5.8 ± 4.5	0	0
Liver metastasis						0.003
No	15	14.0 (4.0–48.0)	17.2 ± 11.9	80.8 %	53.9 %
Yes	7	3.0 (2.0–101.0)	20.0 ± 36.4	28.6 %	14.3 %
Resection of tumor						<0.001
Yes	17	15.0 (2.0–101.0)	21.8 ± 23.6	53.5 %	53.5 %
No	3	6.0 (3.0–12.0)	7.0 ± 4.6	0	0